Showing results (131-140 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|September 7, 2022
Cost Effectiveness of the First-in-Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese SettingXinyue Dong, Xiaoning He, Jing Wu
Pharmacoeconomics|January 7, 2022
Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and SolutionsOlena Mandrik, Chloe Thomas, Sophie Whyte, et al.
Pharmacoeconomics|August 9, 2021
The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the LiteratureBoshen Jiao, Anirban Basu, Joshua Roth, et al.
Pharmacoeconomics|August 9, 2021
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and AssessmentMichael Schlander, Karla Hernandez-Villafuerte, Chih-Yuan Cheng, et al.
Pharmacoeconomics|August 5, 2022
Is EQ-5D-5L Better Than EQ-5D-3L Over Time? A Head-to-Head Comparison of Responsiveness of Descriptive Systems and Value Sets from Nine CountriesMathieu F Janssen, Ines Buchholz, Dominik Golicki, et al.
Pharmacoeconomics|May 5, 2021
The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)Paul E Greenberg, Andree-Anne Fournier, Tammy Sisitsky, et al.
Pharmacoeconomics|May 20, 2021
Overview and Use of Tools for Selecting Modelling Techniques in Health Economic StudiesHuajie Jin, Stewart Robinson, Wenru Shang, et al.
Pharmacoeconomics|May 6, 2021
Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic ReviewJalal Dahham, Rana Rizk, Ingrid Kremer, et al.
Pharmacoeconomics|May 10, 2021
What are the Economic Costs to Society Attributable to Alcohol Use? A Systematic Review and Modelling StudyJakob Manthey, Syed Ahmed Hassan, Sinclair Carr, et al.
Pharmacoeconomics|April 28, 2021
The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive DisorderAlix Arnaud, Ellison Suthoff, Rita M Tavares, et al.
Pageof 335